| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/04/2008 | CN101191123A Application of Walker-256 cell strain in bone tumor pain model establishment |
| 06/04/2008 | CN100392087C Flavivirus vaccine delivery system |
| 06/04/2008 | CN100392077C Carbohydrate oxidase and use thereof in baking |
| 06/04/2008 | CN100392074C Dendritic cell tumor vaccine and its preparation and use |
| 06/04/2008 | CN100392073C Method for breaking up microbe and vegetable cell |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391973C Isolated dendritic cell membrane protein genes |
| 06/04/2008 | CN100391971C Rat's IL-17RE span film region and cell inner region poly peptide and coding sequence, fusion protein and clone |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391469C Remedies for hepatitis C |
| 06/03/2008 | US7381874 Plants and seeds of corn variety I286347 |
| 06/03/2008 | US7381873 Plants and seeds of corn variety I107139 |
| 06/03/2008 | US7381872 Inbred maize line PH58C |
| 06/03/2008 | US7381871 Inbred maize line PH6HR |
| 06/03/2008 | US7381870 Plants and seeds of corn variety I097062 |
| 06/03/2008 | US7381869 Plants and seeds of corn variety I006234 |
| 06/03/2008 | US7381868 Plants and seeds of corn variety I071535 |
| 06/03/2008 | US7381866 Soybean variety 4958786 |
| 06/03/2008 | US7381863 Soybean variety XB27K06 |
| 06/03/2008 | US7381819 Composition for treatment or prevention of endometrial cancer and method of preventing or treating endometrial cancer using the composition |
| 06/03/2008 | US7381813 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 06/03/2008 | US7381810 Polyphenol oxidase genes from lettuce |
| 06/03/2008 | US7381809 Compositions and methods for the treatment of immune related diseases |
| 06/03/2008 | US7381800 Antibodies to HBIMF63 polypeptide |
| 06/03/2008 | US7381798 binds to 2,3,4,7,8-pentachlorodibenzofuran; expression vectors; simple, rapid and sensitive |
| 06/03/2008 | US7381711 Substances for preventing and treating autoimmune diseases |
| 06/03/2008 | US7381709 Method of expressing foreign gene in kidney |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381563 Treating peripherial blood mononuclear cells with a suppressive composition for a time sufficient to induce T cell tolerance; and introducing said cells to said patient. |
| 06/03/2008 | US7381562 Methods for producing cotyledonary pine embryos utilizing a gibberellin |
| 06/03/2008 | US7381561 can initiate neurospheres; comprises contacting with monoclonal antibodies and detecting binding; solid phase synthesis; |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381559 Fermentation flask for cultivating microorganisms |
| 06/03/2008 | US7381554 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/N-acetylglucosamine-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 06/03/2008 | US7381543 TAB1 protein and DNA coding therefore |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 06/03/2008 | US7381523 Methods for identifying compounds for treating diabetes mellitus |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381410 Monoclonal antibodies that bind to epitope and inhibit clustering or phosphorylation between EphB4 and Ephrin B2 |
| 06/03/2008 | US7381408 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 06/03/2008 | US7381405 Stimulating peripheral blood mononuclear cells in vitro with antigen, transducing with retroviral vector and reintroducing into patient |
| 06/03/2008 | CA2340282C Herbicide tolerant brassica juncea and method of production |
| 06/03/2008 | CA2264962C Transcription factor controlling phenylpropanoid biosynthesis pathway |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2220563C Protein production in transgenic alfalfa plants |
| 06/03/2008 | CA2212592C Plant promoter and utilization thereof |
| 06/03/2008 | CA2195528C Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 06/03/2008 | CA2185339C Enhanced expression in a plant plastid |
| 05/29/2008 | WO2008064094A2 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/29/2008 | WO2008064031A2 Potent activation of antigen presenting cells by the hepatitis a virus cellular receptor 1 and its role in the regulation of immune responses |
| 05/29/2008 | WO2008063837A2 Dendritic cell tumor injection therapy and related vaccine |
| 05/29/2008 | WO2008063779A2 Cells expressing alpha-synuclein and uses therefor |
| 05/29/2008 | WO2008063771A2 Anti-cd20 antibodies and methods of use |
| 05/29/2008 | WO2008063759A2 A method of increasing retention, survival and proliferation of transplanted cells in vivo |
| 05/29/2008 | WO2008063675A2 Endodermal progenitor cells |
| 05/29/2008 | WO2008063640A2 Use of bone marrow cells for long term culture of pancreatic islet cells |
| 05/29/2008 | WO2008063577A2 Phospholipase c zeta mediated oocyte activation |
| 05/29/2008 | WO2008063564A2 Isolated myeloid-like cell populations and methods of treatment therewith |
| 05/29/2008 | WO2008063472A2 Method for reducing protease activity in plant hydrolysate |
| 05/29/2008 | WO2008063421A2 Biodegradable t-cell activation device and methods |
| 05/29/2008 | WO2008063418A2 Modified two-component gelation systems, methods of use and methods manufacture |
| 05/29/2008 | WO2008063093A1 Method for hyperproducing target protein in a plant |
| 05/29/2008 | WO2008062904A1 Method of enabling stable expression of transgene |
| 05/29/2008 | WO2008062467A2 Cultured melanocytes on biopolymers |
| 05/29/2008 | WO2008062165A2 Monoterpenoid modifying enzymes |
| 05/29/2008 | WO2008062091A1 Use of non-human mammals lacking vav2 protein expression and/or activity in the cardiovascular, kidney and neurological fields |
| 05/29/2008 | WO2008062063A1 Novel antiproliferation antibodies |
| 05/29/2008 | WO2008061995A2 Genetic ablation of the prp gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals |
| 05/29/2008 | WO2008061392A1 Method for preparing cell populations with anti-tumor immune response activity |
| 05/29/2008 | WO2008061334A1 Lunaria annua, cardamine graeca and teesdalia nudicaulis fae genes and their use in producing nervonic and eicosenoic acids in seed oils |
| 05/29/2008 | WO2008043099A3 Hybrid pacing system |
| 05/29/2008 | WO2008036447A3 Pluripotent stem cell culture |
| 05/29/2008 | WO2007074456A3 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 05/29/2008 | WO2007067828A9 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 05/29/2008 | WO2007034210A8 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 05/29/2008 | WO2006137597A9 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 05/29/2008 | US20080127377 Genetic Constructs Having Heterologous 3' Polyadenylation Signal Sequence Motifs that Function in Plants |
| 05/29/2008 | US20080127372 Grg23 epsp synthases: compositions and methods of use |
| 05/29/2008 | US20080127371 Genes encoding 4-hydroxyphenylpyruvate dioxygenase (hppd) enzymes for plant metabolic engineering |
| 05/29/2008 | US20080127368 Enhancing insect resistance in plants via modifying scent protein expression; biological pest control; disease resistant plants |
| 05/29/2008 | US20080127366 Genes that Alter Capacity to Accumulate Heavy Metals and Salts or Resistance to Heavy Metals, Salts or Drought, and Transformants Expressing the Genes |
| 05/29/2008 | US20080127365 Using vector transformation of leucine zipper homeodomain polypeptide gene sequences as tool in generating plants with enhanced crop yields |
| 05/29/2008 | US20080127363 Flowering Time-Controlling Gene Cog2 Isolated from Arabidopsis Thaliana |
| 05/29/2008 | US20080127362 Transgenic vegetable with curds showing enhanced whiteness; improving commercial desireability of vegetable by altering genetically controlled physical characteristic |
| 05/29/2008 | US20080127360 Pig cell not expressing alpha -1,3-galactosyl transferase and expressing human complement inhibitor and/or human N-acetyl glucosaminyl transferase III for use as transplantation material with dreased possibility of acute rejection |
| 05/29/2008 | US20080127358 Expression vector comprising nucleotide sequences coding cell surface signaling peptides for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/29/2008 | US20080125578 Lipogenase specific immunoglobulin for use in diagnosis, prevention and treatment of physiological, behavioral and inflammatory disorders |
| 05/29/2008 | US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders |
| 05/29/2008 | US20080125487 fatty acid synthase genes involved in the elongation of long-chain polyunsaturated fatty acids, used in the conversion of fatty acids such as gamma-linolenic acid to dihomo-gamma-linolenic acid or stearidonic acid to eicosatetraenoic acid; additives for drugs, cosmetics or feeds |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125417 4-Tert-Butyl-N-(2-methyl-3-{2-[4-(morpholine-4-carbonyl)-phenylamino]-pyrimidin-4-yl}-phenyl)-benzamide;enzyme inhibitors of Burton's tyrosine kinase (Btk); autoimmune diseases; antiinflammatory/-arthritic agents; X-linked agammaglobulinaemia; antiallergens; osteoporosis; determining the presence Btk |
| 05/29/2008 | US20080125409 N-tert-butyl-5-(5-methanesulfonylamino-2-pyridyl)-1-(6-methoxy-3-pyridyl)-1H-1,2,4-triazole-3-carboxamide; prophylactic and/or therapeutic agent for ischemic diseases; platelet aggregation suppressant |
| 05/29/2008 | US20080125390 Methods for Modulating Immune and Inflammatory Responses |
| 05/29/2008 | US20080125388 treating or preventing a condition of excessive cell death by administering a nucleic acid molecule encoding a protein having CPG15-2 biological activity; acts as survival factor by rescuing hippocampal and cortical neurons from cell death; inhibiting activity of CPG15-2 for cancer treatment |
| 05/29/2008 | US20080125373 Motoneuronotrophic factors (MNTF); nerve growth factors; spinal cord injuries; neurodegenerative diseases |
| 05/29/2008 | US20080125369 Soluble t cell receptors |
| 05/29/2008 | US20080125366 Insecticidal proteins derived from Bacillus Thuringiensis |
| 05/29/2008 | US20080125365 Fibronectins; inflammation |